课题基金 / 基金详情

Enrichment

Enrichment
丰富
批准号：
10117241
负责人：
Kari N Nejak-Bowen
金额：
$3.68万
依托单位：
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
项目状态：
已结题
起止时间：
2019-07-01 至 2024-03-30
来源：
https://reporter.nih.gov/project-details/10117241
关键词：
Academic skillsAddressAdvanced DevelopmentAwardBasic ScienceChildhoodClinicClinical ResearchCollaborationsCommunitiesDiseaseEducationEducation and OutreachEducational workshopExhibitsExtramural ActivitiesFacultyFeedbackFibrosisFocus GroupsFosteringFundingFutureGoalsHealthInformation DisseminationInstitutesInstructionJointsKnowledgeLiverMedical centerMedicineMissionPathologyPatient CarePediatric HospitalsPediatricsPhysiciansPostdoctoral FellowProgress ReportsResearchResearch PersonnelResourcesScienceScientistSeriesTimeTraining ActivityTranslational ResearchUniversitiesVisitWorkbasebench to bedsidecareercareer developmentcholestatic liver diseasegraduate studentimprovedinnovationinterdisciplinary approachmemberprogramsskill acquisitionspecial interest groupsuccess

项目摘要

项目成果

Kari N Nejak-Bowen的其他基金

相似基金

相关文献

中文摘要
翻译
根据RFA-DK-18-001说明，摘要/摘要只需要总体
英文摘要
Per the RFA-DK-18-001 instructions, an Abstract/Summary was only required for the Overall Component of the application. No abstract is included in this component.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Beta-catenin inhibition as a novel therapeutic strategy for porphyria
Beta-catenin inhibition as a novel therapeutic strategy for porphyria
Beta-catenin inhibition as a novel therapeutic strategy for porphyria
Beta-catenin inhibition as a novel therapeutic strategy for porphyria
海外基金